What CytoAgents' new $2M grant from NIH will help the biotech firm do
March 10, 2021 at 13:33 PM EST
The company's drug candidate treats a deadly complication of Covid-19 and other respiratory illnesses.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|